5.12.1.4Vertical

Spectroscopy Instruments

Manufacturers of UV-Vis, IR, Raman, NMR, and fluorescence spectrometers.

Market snapshot

These figures describe Analytical Instruments (5.12.1), the segment that Spectroscopy Instruments sits within. They are not figures for Spectroscopy Instruments on its own.

Market size
~$19B
Growth
~4.6%CAGR (2017–22, nominal)
Companies
~550 firms
Firms by employee count

57.8% of firms have fewer than 20 employees: 318 micro-businesses, below most mandates.

The investable universe232 firms with 20+ employees
20–99
12453%
100–499
4720%
500+
6126%

Growth tracks pharmaceutical and biotech R&D budgets rather than industrial activity, which makes it the least cyclical segment here and the most exposed to funding conditions in life sciences. Switching costs are unusually high: methods are validated against a specific instrument and revalidation is a regulatory exercise, so an installed platform is close to annuity revenue.

NAICS 334516. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

Business model & economics

Revenue model

Instrument sales pulling through consumables and service

Key economics

Revenue per firm
$35,189,702
Revenue per employee
$389,063
Employees per firm
84.2
Recurring revenue
High

recurring consumables (columns, reagents) and service

EBITDA margin
Strong

razor-and-blade analytical economics

Capex intensity
Moderate

Characteristics

  • Scale-driven: payroll is only 25% of revenue, so the cost base is assets, not headcount
  • Moderate strategic-buyer pool: 61 firms exceed 500 employees, so a scaled asset has buyers, but not many
  • Consolidated around Thermo Fisher, Agilent, Waters, Danaher.
  • Pharma/biotech R&D and QC and food/environmental testing.
  • High-margin recurring consumables and service.

NAICS 334516. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

Geographic concentration

AlabamaAlaskaArizonaColoradoFloridaGeorgiaIndianaKansasMaineMinnesotaNew JerseyNorth CarolinaNorth DakotaOklahomaPennsylvaniaSouth DakotaTexasWyomingConnecticutMissouriWest VirginiaIllinoisNew MexicoArkansasDelawareDistrict of ColumbiaHawaiiIowaKentuckyMarylandMichiganMississippiMontanaNew HampshireNew YorkOhioOregonTennesseeUtahVirginiaWashingtonWisconsinNebraskaSouth CarolinaIdahoNevadaVermontLouisianaRhode IslandMassachusettsCalifornia

Massachusetts carries nearly four times the national concentration of analytical instrument manufacture, centered on the Boston life-sciences cluster, where the instrument makers sit beside the pharmaceutical and academic customers that specify them.

MassachusettsCalifornia

U.S. Census Bureau, 2022 Statistics of U.S. Businesses (firms by state), NAICS 334516. Concentration shown by location quotient.

M&A deal context

Deal activityHigh

Who’s acquiring

  • Analytical-instrument majors
  • Serial-acquirer platforms
  • PE-backed specialty consolidators

What’s driving deals

  • Consumables and service razor-and-blade economics.
  • Pharma/biotech and emerging-contaminant testing.
  • Serial-acquirer roll-up of specialty instruments.

Find Spectroscopy Instruments acquisition targets

Search Acquisera’s index for companies classified under Spectroscopy Instruments (5.12.1.4) and build a targeted deal pipeline.

Search companies